Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    15269313 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma
Condition: Colorectal Neoplasms
Intervention: Drug: MK-2206 + AZD6244
2 Completed
Has Results
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab;   Drug: BAY 43-9006
3 Active, not recruiting ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction
Conditions: Stomach Neoplasms;   Gastroesophageal Junction Neoplasms
Interventions: Drug: Epirubicin, Cisplatin, Capecitabine, Panitumumab;   Drug: Epirubicin, Cisplatin, Capecitabine
4 Not yet recruiting Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC
Condition: Colorectal Cancer Metastatic
Intervention: Other: treated with FOLFIRI±cetuximab
5 Withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP
6 Terminated Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
Conditions: Colorectal Cancer;   Metastases
Interventions: Drug: Cetuximab;   Drug: Bevacizumab;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Fluorouracil

Study has passed its completion date and status has not been verified in more than two years.